Results 11 to 20 of about 12,647 (196)
Atypical hemolytic uremic syndrome [PDF]
Renal Replacement Therapy, 2017 Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure.
Yoko Yoshida +2 more
doaj +2 more sources
Pediatric Atypical Hemolytic Uremic Syndrome Advances [PDF]
Cells, 2021 Atypical hemolytic uremic syndrome (aHUS) is a rare disorder characterized by dysregulation of the alternate pathway. The diagnosis of aHUS is one of exclusion, which complicates its early detection and corresponding intervention to mitigate its high ...
Rupesh Raina +9 more
doaj +3 more sources
Pregnancy-Associated Atypical Hemolytic-Uremic Syndrome [PDF]
American Journal of Perinatology Reports, 2016 Précis Introduction Early diagnosis of atypical uremic–hemolytic syndrome may be challenging during the puerperium period. Correct diagnosis and timely management are crucial to improve outcomes.
Antonio F. Saad +3 more
doaj +3 more sources
Difficulties in diagnosing atypical hemolytic uremic syndrome [PDF]
Сибирский научный медицинский журнал, 2020 The paper presents the case of clinical observation of a patient with atypical hemolytic-uremic syndrome (aHUS). aHUS is a disease characterized by an unfavorable prognosis (severe or catastrophic course with rapid development of terminal renal or multi ...
N. V. Fomina +5 more
doaj +2 more sources
Atypical hemolytic uremic syndrome: a brief review [PDF]
Hematology Reports, 2017 Atypical hemolytic uremic syndrome (aHUS) is a disease characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury.
Kuixing Zhang +3 more
doaj +5 more sources
Eculizumab in atypical hemolytic-uremic syndrome [PDF]
New England Journal of Medicine, 2013 To the Editor: With regard to the article by Legendre et al. (June 6 issue)(1): assessment of the 37 patients with atypical hemolytic-uremic syndrome is difficult, since the process of selection seems opaque, particularly for the 20 patients in trial 2.
Kistler, Andreas D
core +10 more sources
Atypical hemolytic uremic syndrome [PDF]
Hematology, 2016 AbstractAtypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) that affects multiple organs and the kidneys in particular. aHUS can be sporadic or familial and is most commonly caused by dysregulation of the alternative complement pathway.
Ali, Nayer, Arif, Asif
openaire +4 more sources
Atypical Hemolytic Uremic Syndrome [PDF]
Seminars in Nephrology, 2013 Hemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. The atypical form of HUS is a disease characterized by complement overactivation. Inherited defects in complement genes and acquired autoantibodies against complement regulatory proteins have been described.
Kavanagh D, Goodship TH, Richards A
openaire +3 more sources
Atypical Hemolytic Uremic Syndrome
Pediatric Clinics of North America, 2018 Atypical hemolytic uremic syndrome is a rare life-threatening disease of unregulated complement activation. Untreated, the prognosis is generally poor; more than one-half of patients die or develop end-stage renal disease within 1 year. Atypical hemolytic uremic syndrome is characterized by thrombotic microangiopathy with evidence of hemolysis ...
Bradley P. Dixon, Ralph A. Gruppo
+7 more sources
Analysis of linear antibody epitopes on factor H and CFHR1 using sera of patients with autoimmune atypical hemolytic uremic syndrome [PDF]
, 2017 Introduction: In autoimmune atypical hemolytic uremic syndrome (aHUS), the complement regulator factor H (FH) is blocked by FH autoantibodies, while 90% of the patients carry a homozygous deletion of its homolog complement FH-related protein 1 (CFHR1 ...
Csuka, Dorottya +8 more
core +5 more sources